Abstract
Upfront resection for pancreatic cancer has a high incidence of margin positive resection. The six different technical descriptions of artery first approaches to pancreatic cancer aimed to identify a positive SMA margin at an earlier stage during pancreatoduodenectomy and avoid a futile margin positive resection. Each approach has a technical justification providing exposure to SMA along its course from the aorta, through the pancreas into the small bowel mesentery depending on the location of the tumor within the pancreas. Several retrospective studies showed improved perioperative and survival outcomes with an artery first approach including a reduction in R1 resections, which were further confirmed in systematic reviews comparing the artery first pancreatoduodenectomy with standard pancreatoduodenectomy. However more recent evidence from randomised controlled trials to corroborate this is lacking. Further trials are warranted comparing various artery first approaches with standard pancreatoduodenectomy before it is considered standard of care.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Groot VP, Rezaee N, Wu W, Cameron JL, Fishman EK, Hruban RH, Weiss MJ, Zheng L, Wolfgang CL, He J. Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2018;267(5):936–45.
Tanaka M, Mihaljevic AL, Probst P, Heckler M, Klaiber U, Heger U, Büchler MW, Hackert T. Meta-analysis of recurrence pattern after resection for pancreatic cancer. Br J Surg. 2019;106(12):1590–601.
Sanjay P, Takaori K, Govil S, Shrikhande SV, Windsor JA. ‘Artery-first’ approaches to pancreatoduodenectomy. Br J Surg. 2012;99(8):1027–35.
Nakao A, Takagi H. Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein. Hepato-Gastroenterology. 1993;40:426–9.
Pessaux P, Varma D, Arnaud J. Pancreatoduodenectomy: superior mesenteric artery first approach. J Gastrointest Surg. 2006;10:607–11.
Vallance A, Young A, Pandanaboyana S, Lodge JP, Smith AM. Posterior superior mesenteric artery first dissection versus classical approach in pancreaticoduodenectomy: outcomes of a case-matched study. Pancreas. 2017;46:276–81.
Hackert T, Werner J, Weitz J, Schmidt J, Büchler MW. Uncinate process first—a novel approach for pancreatic head resection. Langenbeck’s Arch Surg. 2010;395:1161–4.
Shukla PJ, Barreto G, Pandey D, Kanitkar G, Nadkarni MS, Neve R, et al. Modification in the technique of pancreaticoduodenectomy: supracolic division of jejunum to facilitate uncinate process dissection. Hepato-Gastroenterology. 2007;54:1728–30.
Kurosaki I, Minagawa M, Takano K, Takizawa K, Hatakeyama K. Left posterior approach to the superior mesenteric vascular pedicle in pancreaticoduodenectomy for cancer of the pancreatic head. JOP. 2011;12:220–9.
Weitz J, Rahbari N, Koch M, Büchler MW. The artery first approach for resection of pancreatic head cancer. J Am Coll Surg. 2010;210:e1–4.
Hirota M, Kanemitsu K, Takamori H, Chikamoto A, Tanaka H, Sugita H, et al. Pancreatoduodenectomy using a no-touch isolation technique. Am J Surg. 2010;199:e65–8.
Barreto SG, Loveday B, Windsor JA, Pandanaboyana S. Detecting tumour response and predicting resectability after neoadjuvant therapy for borderline resectable and locally advanced pancreatic cancer. ANZ J Surg. 2019;89(5):481–7.
Nagakawa Y, Hosokawa Y, Sahara Y, Takishita C, Nakajima T, Hijikata Y, Tago T, Kasuya K, Tsuchida A. A novel “artery first” approach allowing safe resection in laparoscopic pancreaticoduodenectomy: the uncinate process first approach. Hepato-Gastroenterology. 2015;62:1037–40.
Chen XM, Sun DL, Zhang Y. Laparoscopic versus open pancreaticoduodenectomy combined with uncinated process approach: a comparative study evaluating perioperative outcomes (retrospective cohort study). Int J Surg. 2018;51:170–3.
Pędziwiatr M, Pisarska M, Małczak P, Major P, Wierdak M, Radkowiak D, Kulawik J, Dembiński M, Budzyński A. Laparoscopic uncinate process first pancreatoduodenectomy-feasibility study of a modified ‘artery first’ approach to pancreatic head cancer. Langenbeck’s Arch Surg. 2017;402(6):917–23.
Negoi I, Hostiuc S, Runcanu A, Negoi RI, Beuran M. Superior mesenteric artery first approach versus standard pancreaticoduodenectomy: a systematic review and meta-analysis. Hepatobiliary Pancreat Dis Int. 2017;16(2):127–38.
Ironside N, Barreto SG, Loveday B, Shrikhande SV, Windsor JA, Pandanaboyana S. Meta-analysis of an artery-first approach versus standard pancreatoduodenectomy on perioperative outcomes and survival. Br J Surg. 2018;105(6):628–36.
Jiang X, Yu Z, Ma Z, Deng H, Ren W, Shi W, Jiao Z. Superior mesenteric artery first approach can improve the clinical outcomes of pancreaticoduodenectomy: A meta-analysis. Int J Surg. 2020;73:14–24.
Gall T, Jacob J, Frampton A, Krell J. Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer. JAMA Surg. 2014;149:482–5.
Sabater L, Cugat E, Serrablo A, Suarez-Artacho G, Diez-Valladares L, Santoyo-Santoyo J, et al. Does the artery-first approach improve the rate of R0 resection in Pancreatoduodenectomy?: a multicenter, randomized, controlled trial. Ann Surg. 2019;270(5):738–46.
Hirono S, Kawai M, Okada KI, et al. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for pancreatic cancer during pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma. Trials. 2018;19:613.
Nickel F, Haney CM, Kowalewski KF, Probst P, Limen EF, Kalkum E, Diener MK, Strobel O, Müller-Stich BP, Hackert T. Laparoscopic versus open pancreaticoduodenectomy: a systematic review and meta-analysis of randomized controlled trials. Ann Surg. 2019;271:54–66, [Epub ahead of print]. https://doi.org/10.1097/SLA.0000000000003309.
van Hilst J, de Rooij T, Bosscha K, Brinkman DJ, van Dieren S, Dijkgraaf MG, et al. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial. Lancet. 2019;4(3):199–207.
Inoue Y, Saiura A, Oba A, Kawakatsu S, Ono Y, Sato T, Mise Y, Ishizawa T, Takahashi Y, Ito H. Optimal extent of superior mesenteric artery dissection during pancreaticoduodenectomy for pancreatic cancer: balancing surgical and oncological safety. J Gastrointest Surg. 2019;23(7):1373–83.
Jang JY, Han Y, Lee H, Kim SW, Kwon W, et al. Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter phase 2/3 trial. Ann Surg. 2018;268(2):215–22.
Versteijne E, van Eijck CH, Punt CJ, et al. Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial. Trials. 2016;17(1):127. Published 2016 Mar 9. https://doi.org/10.1186/s13063-016-1262-z.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
French, J.J., Pandanaboyana, S. (2021). The Artery-First Approach in Pancreatic Cancer Surgery. In: Søreide, K., Stättner, S. (eds) Textbook of Pancreatic Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-53786-9_55
Download citation
DOI: https://doi.org/10.1007/978-3-030-53786-9_55
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-53785-2
Online ISBN: 978-3-030-53786-9
eBook Packages: MedicineMedicine (R0)